Details for New Drug Application (NDA): 218174
✉ Email this page to a colleague
NDA 218174 describes LURASIDONE HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Annora Pharma, Aurobindo Pharma Ltd, Avet Lifesciences, Dr Reddys, Invagen Pharms, Lupin Ltd, Macleods Pharms Ltd, MSN, Slate Run Pharma, Sun Pharm, Teva Pharms Usa, Torrent, Watson Labs Teva, and Zydus Pharms, and is included in eighteen NDAs. It is available from twenty-six suppliers. Additional details are available on the LURASIDONE HYDROCHLORIDE profile page.
The generic ingredient in LURASIDONE HYDROCHLORIDE is lurasidone hydrochloride. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the lurasidone hydrochloride profile page.
The generic ingredient in LURASIDONE HYDROCHLORIDE is lurasidone hydrochloride. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the lurasidone hydrochloride profile page.
Summary for 218174
| Tradename: | LURASIDONE HYDROCHLORIDE |
| Applicant: | Annora Pharma |
| Ingredient: | lurasidone hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 218174
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 218174 | ANDA | Camber Pharmaceuticals, Inc. | 31722-080 | 31722-080-05 | 500 TABLET, FILM COATED in 1 BOTTLE (31722-080-05) |
| LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 218174 | ANDA | Camber Pharmaceuticals, Inc. | 31722-080 | 31722-080-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-080-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
| Approval Date: | Aug 21, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Aug 21, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
| Approval Date: | Aug 21, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
